Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Always consult with your provider about risks based on your health profile
I would hesitate to compare the degree of weight loss that we saw in our study findings with the literature thats out there in the phase 3 studies, because most of our patients, almost 80%, were getting the GLP-1 agonist for diabetes, not for weight management
This guide maps every common GLP-1 switch to its conservative equivalent dose, explains why the numbers look the way they do, and covers what to expect in the first few weeks after changing over
Retatrutide's profile will sharpen as the remaining seven TRIUMPH trials report over 2026
High-protein, moderate-fiber meals tend to be tolerated best
And for anyone for whom maximum weight loss is the priority, the injectables Mounjaro and Wegovy still set the pace
US$ 27.57
US$ 29.42
US$ 29.54
US$ 23.21
US$ 23.34
US$ 27.49
US$ 24.55
